Find latest AML videos · 300+ videos
E

GVHD: Importance of Early Detection and Management

By Ernst Holler
267 views
May 24, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

14:18
Incyte

Early Intervention in Chronic GVHD: Evaluating Efficacy and Safety O…

Feat. H. Ali

Featured Video

09:50
Incyte

Managing Chronic GVHD Master Class Series: Best Practices at 100 Day…

Feat. C. Cutler

Related Videos

International Congress on Cancer Metastasis

10th International Congress on Cancer Metastasis

Wed, Oct 29, 2025
25:03

ASH 2024 Summary: Highlights in AML, MDS, and ALL

2024 ASH Annual Meeting Insights Hub

T. Badar

1.4K views
19:01

Debates in AML: 7+3 Is No Longer the Standard of Care

XV Eurasian Hematology-Oncology Congress - EHOC 2024

T. Kadia

1.2K views
19:19

ASH 2024 Summary: Highlights in Adult ALL and Implications for Pract…

2024 ASH Annual Meeting Insights Hub

R. Cassaday

398 views
12:55

ASH 2024 Summary: Menin Inhibitors in AML - FDA Approval and Highlig…

2024 ASH Annual Meeting Insights Hub

J. Zeidner

475 views
33:01

2024 Updates on Management of DLBCL

Louisville Hematology Highlights

J. Leonard

464 views
11:49

ASH 2025 Review: Updates in Frontline & R/R DLBCL

University of Colorado Division of Hematology

M. Kamdar

210 views
21:24

ASH 2024 Insights: Venetoclax + Aza for 1L Younger AML Pts Independe…

2024 ASH Annual Meeting Insights Hub

J. Watts

373 views
21:05

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

4.9K views
16:57

ASCO® 2024 Summary: "Lymphoma Highlights"

2024 ASCO® Annual Meeting Insights Hub

B. D. Cheson

1.8K views
15:16

ASH 2024 Summary: Transplant Options and Outcomes for TP53 Myeloid D…

2024 ASH Annual Meeting Insights Hub

H. Fernandez

273 views
33:46

ASH 2024 Review: Key Updates in Non-Hodgkin Lymphoma

Cleveland Clinic Taussig Cancer Institute

P. Caimi

233 views
22:14

Treating Patients With DLBCL Who Are Not Eligible for CAR-T Therapy

Remy Dulery

315 views
16:16

ASH 2024 Summary: Highlights in Ph- ALL

2024 ASH Annual Meeting Insights Hub

F. Haddad

200 views
10:27

Sequencing Cellular Therapy and Bispecific Antibodies in DLBCL

Megan Melody

248 views
25:44

Myeloid Malignancies: Hot Topics in 2024

Yale Cancer Center

N. Podoltsev

431 views
26:58

Understanding the AML Disease State: Key Challenges and Advances

Cleveland Clinic Taussig Cancer Institute

M. Mustafa Ali

133 views
35:03

Advancements in AML Management in 2024

Louisville Hematology Highlights

C. Lachowiez

240 views
27:49

AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024

Insights from 2024 EHA Annual Meeting

T. Badar

840 views
27:03

ASH 2024 Review: Updates on the Management of MDS

Cleveland Clinic Taussig Cancer Institute

H. Carraway

156 views
19:10

Steroid-Refractory GVHD Updates

Roswell Park Comprehensive Cancer Center

S. Holtan

219 views
AUTOPLAY